home
RSS
Flu drugs may not be worth stockpiling
April 10th, 2014
02:23 PM ET

Flu drugs may not be worth stockpiling

Tamiflu, commonly used to reduce flu symptoms, may not work as well as the federal government believed when it spent more than $1.3 billion stockpiling it.

The Cochrane Collaboration, a nonprofit network of health practitioners, researchers and patient advocates, recently analyzed 46 clinical study reports on Tamiflu and another influenza drug called Relenza to determine their effectiveness.

The researchers concluded that while both drugs can stop adults' symptoms about half a day earlier, on average, than no treatment, the drugs do not reduce the rate of serious influenza complications, such as hospitalizations and pneumonia. The results were published this week in the British Medical Journal.

"A significant number of doctors see them as pretty mediocre drugs that don't do a whole bunch," said Dr. Peter Doshi, an assistant professor at the University of Maryland School of Pharmacy and associate editor at BMJ.
FULL POST


Advertisement
About this blog

Get a behind-the-scenes look at the latest stories from CNN Chief Medical Correspondent, Dr. Sanjay Gupta, Senior Medical Correspondent Elizabeth Cohen and the CNN Medical Unit producers. They'll share news and views on health and medical trends - info that will help you take better care of yourself and the people you love.

Advertisement
Advertisement